Literature DB >> 7019934

Substrate interaction with cytochrome P-450.

J B Schenkman, S G Sligar, D L Cinti.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7019934     DOI： 10.1016/0163-7258(81)90075-9

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  15 in total

1.  CYP153A6, a soluble P450 oxygenase catalyzing terminal-alkane hydroxylation.

Authors:  Enrico G Funhoff; Ulrich Bauer; Inés García-Rubio; Bernard Witholt; Jan B van Beilen
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

Review 2.  Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

3.  Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition.

Authors:  Tsutomu Shimada; Donghak Kim; Norie Murayama; Katsuhiro Tanaka; Shigeo Takenaka; Leslie D Nagy; Lindsay M Folkman; Maryam K Foroozesh; Masayuki Komori; Hiroshi Yamazaki; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-03-13       Impact factor: 3.739

4.  Ligand characterization of CYP4B1 isoforms modified for high-level expression in Escherichia coli and HepG2 cells.

Authors:  Katharina Roellecke; Vera D Jäger; Veselin H Gyurov; John P Kowalski; Stephanie Mielke; Allan E Rettie; Helmut Hanenberg; Constanze Wiek; Marco Girhard
Journal:  Protein Eng Des Sel       Date:  2017-03-01       Impact factor: 1.650

5.  Drug metabolism in spontaneously diabetic guinea pigs.

Authors:  D E Cook; J D Jackson; M R Past; C M Lang; L P Bullock
Journal:  Experientia       Date:  1984-08-15

6.  The kinetic mechanism for cytochrome P450 metabolism of type II binding compounds: evidence supporting direct reduction.

Authors:  Joshua Pearson; Upendra P Dahal; Daniel Rock; Chi-Chi Peng; James O Schenk; Carolyn Joswig-Jones; Jeffrey P Jones
Journal:  Arch Biochem Biophys       Date:  2011-04-21       Impact factor: 4.013

7.  Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.

Authors:  Chi-Chi Peng; Jonathan L Cape; Tom Rushmore; Gregory J Crouch; Jeffrey P Jones
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 8.  Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.

Authors:  J-D Maréchal; C A Kemp; G C K Roberts; M J I Paine; C R Wolf; M J Sutcliffe
Journal:  Br J Pharmacol       Date:  2007-11-19       Impact factor: 8.739

9.  2,2',3,3',6,6'-Hexachlorobiphenyl (PCB 136) atropisomers interact enantioselectively with hepatic microsomal cytochrome P450 enzymes.

Authors:  Izabela Kania-Korwel; Eugene G Hrycay; Stelvio M Bandiera; Hans-Joachim Lehmler
Journal:  Chem Res Toxicol       Date:  2008-05-22       Impact factor: 3.739

10.  Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquine.

Authors:  J O Atiba; T F Blaschke; G R Wilkinson
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.